51552-68-2

Basic information

• Product Name: Methyl 7-quinolinecarboxylate
• Synonyms: Methyl 7-quinolinecarboxylate;Methyl quinoline-7-carboxylate;Quinoline-7-carboxylic acid methyl ester;7-Quinolinecarboxylic acid, methyl ester
• CAS NO: 51552-68-2
• Molecular Formula: C₁₁H₉NO₂
• Molecular Weight: 187.19466
• Mol File: 51552-68-2.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 315.1±15.0 °C(Predicted)
• Appearance: /
• Density: 1.210±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 2.95±0.14(Predicted)
• CAS DataBase Reference: Methyl 7-quinolinecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 7-quinolinecarboxylate(51552-68-2)
• EPA Substance Registry System: Methyl 7-quinolinecarboxylate(51552-68-2)

Safety Data

• Hazardous Substances Data: 51552-68-2(Hazardous Substances Data)

Usage

General Description

Methyl 7-quinolinecarboxylate is a chemical compound with the molecular formula C11H9NO2. It is a derivative of quinoline, a heterocyclic aromatic compound, and contains a methyl ester functional group. Methyl 7-quinolinecarboxylate is used in various industrial and research applications, including as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has also been studied for its potential biological activities, such as its antimicrobial and antiviral properties. Additionally, it can be used as a fluorescence probe in chemical and biological research due to its fluorescent properties.

Upstream product

• 67-56-1 methanol 
• 4965-36-0 7-bromoquinoline 
• 201230-82-2 carbon monoxide 
• 1078-30-4 quinoline-7-carboxylic acid 
• 346-55-4 4-chloro-7-trifluoromethyl quinoline 
• 186581-53-3 diazomethane 
• 325-14-4 7‐(trifluoromethyl)quinoline 

Downstream Products

• 49713-58-8 4‐chloroquinoline‐7‐carboxylic acid 
• 1150618-22-6 4-hydroxyquinoline-7-carboxylic acid 
• 178984-69-5 7-Methyloxycarbonyl-4-chloroquinoline 
• 1416801-65-4 methyl 2-chloro-quinoline-7-carboxylate 
• 49573-30-0 quinoline-7-carbaldehyde 
• 1034776-76-5 1-(2-methoxy-5-methyl-benzenesulfonyl)-1,2,3,4-tetrahydro-quinoline-7-carboxylic acid 
• 1034776-74-3 1-(2-methoxy-5-methyl-benzenesulfonyl)-1,2,3,4-tetrahydro-quinoline-7-carboxylic acid methyl ester 
• 1451154-40-7 methyl 2-methoxyquinoline-7-carboxylate 
• 1374258-40-8 2-methoxyquinoline-7-carboxylic acid 
• 597562-79-3 methyl 1,2,3,4-tetrahydroquinoline-7-carboxylate 
• 1078-30-4 quinoline-7-carboxylic acid 
• 188874-61-5 7-bromomethyl-quinoline hydrobromide 

Relevant articles and documents

TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

A compound of general formula (I): wherein: n is 1, 2 or 3; R1, R2, R3 and R4, independently represent OH or Q; and 20 Q represents a tissue-targeting moeity selected from the group consisting of or a stereoisomer, a hydrate, a solvate, or a salt thereof, or a mixture of same, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said 25 compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of soft tissue diseases, as a sole agent or in combination with other active ingredients.

N1/N2-Lactam Acetyl-CoA carboxylase inhibitors

The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal

2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof

Fused heterocyclic compounds are provided according to formula 1: where R1, R2, R3, and m are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.